267 related articles for article (PubMed ID: 32196917)
1. Age-specific associations of glycated haemoglobin variability with cardiovascular disease and mortality in patients with type 2 diabetes mellitus: A 10- year cohort study.
Wan EYF; Yu EYT; Chin WY; Ng FTY; Chia SMC; Wong ICK; Chan EWY; Lam CLK
Diabetes Obes Metab; 2020 Aug; 22(8):1316-1327. PubMed ID: 32196917
[TBL] [Abstract][Full Text] [Related]
2. Associations between usual glycated haemoglobin and cardiovascular disease in patients with type 2 diabetes mellitus: A 10-year diabetes cohort study.
Wan EY; Yu EY; Chen JY; Wong IC; Chan EW; Lam CL
Diabetes Obes Metab; 2020 Dec; 22(12):2325-2334. PubMed ID: 32744402
[TBL] [Abstract][Full Text] [Related]
3. Association of variability in hemoglobin A1c with cardiovascular diseases and mortality in Chinese patients with type 2 diabetes mellitus - A retrospective population-based cohort study.
Wan EY; Fung CS; Fong DY; Lam CL
J Diabetes Complications; 2016; 30(7):1240-7. PubMed ID: 27318537
[TBL] [Abstract][Full Text] [Related]
4. Association of glycated hemoglobin A
Sinning C; Makarova N; Völzke H; Schnabel RB; Ojeda F; Dörr M; Felix SB; Koenig W; Peters A; Rathmann W; Schöttker B; Brenner H; Veronesi G; Cesana G; Brambilla P; Palosaari T; Kuulasmaa K; Njølstad I; Mathiesen EB; Wilsgaard T; Blankenberg S; Söderberg S; Ferrario MM; Thorand B
Cardiovasc Diabetol; 2021 Nov; 20(1):223. PubMed ID: 34781939
[TBL] [Abstract][Full Text] [Related]
5. Greater variability in lipid measurements associated with cardiovascular disease and mortality: A 10-year diabetes cohort study.
Wan EYF; Yu EYT; Chin WY; Barrett JK; Mok AHY; Lau CST; Wang Y; Wong ICK; Chan EWY; Lam CLK
Diabetes Obes Metab; 2020 Oct; 22(10):1777-1788. PubMed ID: 32452623
[TBL] [Abstract][Full Text] [Related]
6. Age-Specific Associations of Usual Blood Pressure Variability With Cardiovascular Disease and Mortality: 10-Year Diabetes Mellitus Cohort Study.
Wan EYF; Yu EYT; Chin WY; Barrett JK; Wong ICK; Chan EWY; Chui CSL; Chen S; Lam CLK
J Am Heart Assoc; 2021 Sep; 10(17):e019026. PubMed ID: 34398678
[TBL] [Abstract][Full Text] [Related]
7. Visit-to-Visit Variability of Hemoglobin A
Ghouse J; Skov MW; Kanters JK; Lind B; Isaksen JL; Blanche P; Haunsø S; Køber L; Svendsen JH; Olesen MS; Holst AG; Gerds TA; Nielsen JB
Diabetes Care; 2019 Jan; 42(1):134-141. PubMed ID: 30352898
[TBL] [Abstract][Full Text] [Related]
8. Diabetes Mellitus-Related All-Cause and Cardiovascular Mortality in a National Cohort of Adults.
Raghavan S; Vassy JL; Ho YL; Song RJ; Gagnon DR; Cho K; Wilson PWF; Phillips LS
J Am Heart Assoc; 2019 Feb; 8(4):e011295. PubMed ID: 30776949
[TBL] [Abstract][Full Text] [Related]
9. The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease.
Bots SH; van der Graaf Y; Nathoe HM; de Borst GJ; Kappelle JL; Visseren FL; Westerink J;
Cardiovasc Diabetol; 2016 Jul; 15(1):101. PubMed ID: 27431507
[TBL] [Abstract][Full Text] [Related]
10. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry.
Luk AO; Ma RC; Lau ES; Yang X; Lau WW; Yu LW; Chow FC; Chan JC; So WY
Diabetes Metab Res Rev; 2013 Jul; 29(5):384-90. PubMed ID: 23463747
[TBL] [Abstract][Full Text] [Related]
11. Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study.
Kim MK; Jeong JS; Yun JS; Kwon HS; Baek KH; Song KH; Ahn YB; Ko SH
J Diabetes Complications; 2018 Oct; 32(10):906-910. PubMed ID: 30121206
[TBL] [Abstract][Full Text] [Related]
12. Diabetes with poor-control HbA1c is cardiovascular disease 'risk equivalent' for mortality: UK Biobank and Hong Kong population-based cohort study.
Wan EYF; Yu EYT; Mak IL; Youn HM; Chan KS; Chan EWY; Wong ICK; Lam CLK
BMJ Open Diabetes Res Care; 2023 Jan; 11(1):. PubMed ID: 36634978
[TBL] [Abstract][Full Text] [Related]
13. Limited benefit of haemoglobin glycation index as risk factor for cardiovascular disease in type 2 diabetes patients.
Østergaard HB; Mandrup-Poulsen T; Berkelmans GFN; van der Graaf Y; Visseren FLJ; Westerink J;
Diabetes Metab; 2019 Jun; 45(3):254-260. PubMed ID: 29784563
[TBL] [Abstract][Full Text] [Related]
14. Associations between glycated hemoglobin and the risks of incident cardiovascular diseases in patients with gout.
Li L; Lip GYH; Li S; Adachi JD; Thabane L; Li G
Cardiovasc Diabetol; 2022 Jul; 21(1):133. PubMed ID: 35841094
[TBL] [Abstract][Full Text] [Related]
15. Prognostic importance of baseline and serial glycated hemoglobin levels in high-risk patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CR; Leite NC; Ferreira MT; Salles GF
Acta Diabetol; 2015 Feb; 52(1):21-9. PubMed ID: 24816865
[TBL] [Abstract][Full Text] [Related]
16. Glycated hemoglobin variability and the risk of cardiovascular events in patients with prediabetes and type 2 diabetes mellitus: A post-hoc analysis of a prospective and multicenter study.
Manosroi W; Phimphilai M; Waisayanand N; Buranapin S; Deerochanawong C; Gunaparn S; Phrommintikul A; Wongcharoen W;
J Diabetes Investig; 2023 Dec; 14(12):1391-1400. PubMed ID: 37610280
[TBL] [Abstract][Full Text] [Related]
17. Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes.
Orsi E; Solini A; Bonora E; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Gruden G; Morano S; Nicolucci A; Penno G; Pugliese G;
Diabetes Obes Metab; 2018 Aug; 20(8):1885-1893. PubMed ID: 29582548
[TBL] [Abstract][Full Text] [Related]
18. Diabetes duration and glycaemic control as predictors of cardiovascular disease and mortality.
Li FR; Yang HL; Zhou R; Zheng JZ; Chen GC; Zou MC; Wu XX; Wu XB
Diabetes Obes Metab; 2021 Jun; 23(6):1361-1370. PubMed ID: 33620747
[TBL] [Abstract][Full Text] [Related]
19. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR).
Eeg-Olofsson K; Cederholm J; Nilsson PM; Zethelius B; Svensson AM; Gudbjörnsdóttir S; Eliasson B
J Intern Med; 2010 Nov; 268(5):471-82. PubMed ID: 20804517
[TBL] [Abstract][Full Text] [Related]
20. Glycemic control and risk of cardiovascular disease hospitalization and all-cause mortality.
Nichols GA; Joshua-Gotlib S; Parasuraman S
J Am Coll Cardiol; 2013 Jul; 62(2):121-127. PubMed ID: 23665365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
